Dear colleagues from the European Community of Nanomedicine, we are pleased to share with you today some job offers to join the laboratory of Professor María José Alonso at the Universidad De Santiago de Compostela, Spain .
- Scientific project manager for a project on a new COVID19 nanotherapy: https://www.usc.
es/grupos/mjalonsolab/job- offer-covid-nanotherapy/ ( DEADLINE: 28/02/2022)
- Technical assistant contract offer with Prof. M.J. Alonso : https://www.usc.es/grupos/
mjalonsolab/job-offer- technical-assistant/ ( DEADLINE: 28/02/2022)
- Post-doctoral students for a project on: Theranostics of Glioblastoma using Nanotechnology: https://www.
usc.es/grupos/mjalonsolab/job- offer-post-doctoral-students- diagbi/ (DEADLINE: 28/02/2022)
- Technology Transfer & Valorization Manager: https://www.usc.es/
grupos/mjalonsolab/job-offer- technolgy-transfer- valorization/ (DEADLINE: 28/03/2022)
About Prof. María José Alonso
Dept. of Pharmacy and Pharmaceutical Technology, USC
CIMUS Research Institute
María José Alonso’s lab has pioneered numerous discoveries in the field of Nanopharmaceutical Technology and nanomedicine. She has coordinated several research consortia financed by the WHO, the Gates Foundation and the European Commission. She has participated in 16 international projects. She is the author of 300 scientific contributions with more than 34,000 cites (H factor 98) and the inventor of 22 patent families. Because of the quality of her scientific articles she has been among the TOP TEN in Pharmacology (Times Higher Education international ranking, 2010) and she is on ‘The Power List’ of the most influential researchers in the field of Biopharmaceuticals (The Medicine Maker, 2020-21). She was former President of the Controlled Release Society and she is currently Editor-in-Chief of the Drug Delivery and Translational Research. In 2006-10, she was the Vice-rector of Research and Innovation of the USC. She is a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and of the Controlled Release Society (CRS), a member of three Academies in Spain, a member of the US National Academy of Medicine (NAM) and a member of the Royal Academy of Medicine of Belgium. Recently, she received the National Sciences Award ‘Juan de la Cierva’, the most prestigious award given to Spanish Scientists.
Main areas of research of Prof. Alonso’s Lab
- Creating new conceptual approaches for delivering protein drugs and genes across complex barriers in the body, such as the nasal, ocular and intestinal barriers (Projects named as TRANSINT, NABBA, NANOFAR, SURFEYE).
- Designing and developing new nanocarriers for antigen delivery and investigating their adjuvant properties (nanovaccines) (NANOPILOT, NANOFAR).
- Designing and developing nano-oncological therapies consisting of multifunctional nanocarriers targeted to the tumor cells, the tumor associated macrophages (TAM) and the lymphatic vessels (NICHE, NANOFAR, WORLDWIDE CANCER Research Consortium).